Royal Care Hospital Unlisted Share Price Today
Royalcare Super Speciality Hospitals unlisted share price is ₹155 per share (indicative, as of 17 Oct 2026). Minimum ticket ₹25,000 (lot of 165 shares), the same for every company. Sector: Consumer. Status: unlisted, no DRHP on record.
All unlisted share prices: dated indicative prices for every company the desk tracks.
Updated 17 Oct 2026, 22:10 IST. Dated dealer references.
BuyUnlistedShares tracks 230 unlisted companies with dated prices; Royalcare Super Speciality Hospitals’s indicative price is ₹155 per share as of 17 Oct 2026, a lot of 165 shares.
Key facts
- Indicative price
- ₹155 per share
- Price as of
- 17 Oct 2026
- Minimum investment
- ₹25,000
- Lot size
- 165 shares
- Sector
- Consumer
- Listing status
- Unlisted
- Settlement
- Demat to demat; terms agreed in writing for each deal
- Last updated
- 17 Oct 2026, 22:10 IST
Indicative and dated. BuyUnlistedShares deals as principal.
Buying at a glance
- Minimum ticket
- ₹25,000
- Price shown
- Indicative, dated 17 Oct 2026
- Delivery
- Shares are credited to your demat account
In plain words
- Lock-in if it lists
- Shares bought before an IPO are generally locked in for six months from the IPO allotment date under SEBI rules. The issue documents set the exact terms.
- IPO status
- Unlisted. No DRHP on record.
Facts only, not a rating or a recommendation.
Compare it against the full unlisted share price list: every company the desk quotes, each with a dated indicative price.
Indicative move: -3.1% over 3 months.
Key figures
| Market cap | ₹2,924.21 Cr |
|---|---|
| Minimum investment | ₹25,000 |
| Lot size | 165 |
| P/E ratio | 122.05x |
| ROE | 5.87% |
| Book value | ₹16.84 |
| Face value | ₹10 |
| 52-week high | ₹160 |
| 52-week low | ₹142 |
| ISIN | — |
| Dividend yield | — |
Financials (₹ Cr)
| Metric | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | 305 | 333 | 353 |
| PAT | 16.0 | 24.5 | 15.1 |
| EPS (₹) | 0.97 | 1.46 | 0.84 |
About the company
Royalcare Super Speciality Hospital Limited is a Coimbatore-based healthcare company that owns and operates a large multi-disciplinary tertiary care hospital in Tamil Nadu. Incorporated in 2012, the company began clinical operations in 2015 and has since scaled into one of the region's prominent ultramodern hospital facilities, with bed capacity that has grown into the several-hundred-bed range…
Prices shown are indicative and dated. Unlisted shares are illiquid and values can move sharply.
Registered in Coimbatore, Tamil Nadu.
Registry
- ISIN: —
- Depository: NSDL & CDSL
- Listed at: Unlisted
- Price as of: 17 Oct 2026
Company facts
| CIN | U85100TZ2012PLC018984 |
|---|---|
| Incorporated | 2012 |
| ISIN | INE02C801010 |
| Face value | ₹10 |
| Registered office | Door No. 1/520, Neelambur, Sulur Taluk, Coimbatore 641062, Tamil Nadu, India |
| Shares outstanding | 18,86,58,478 |
| Lot size | 165 shares |
| Minimum units | 65 |
| DRHP | Not filed |
Financial statements (₹ Cr)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 vs FY25 |
|---|---|---|---|---|---|---|
| Revenue | 301 | 305 | 332.73 | 352.57 | 449 | +27.4% |
| EBITDA | — | 61 | 67 | 65.7 | 77.2 | +17.5% |
| Profit before tax | — | 16 | 24 | 13.5 | 33.6 | +148.9% |
| Profit after tax | 21 | 16 | 24.48 | 15.05 | 26 | +72.8% |
| EPS (₹) | 1.28 | 0.97 | 1.46 | 0.84 | 1.27 | — |
| Operating margin | — | — | 14.4% | 11.3% | — | — |
| Net margin | — | — | 7.4% | 4.3% | — | — |
| Share capital | — | — | 171.02 | 188.66 | — | — |
| Reserves & surplus | — | — | 23.7 | 129.11 | — | — |
| Net worth | — | — | 194.72 | 317.77 | — | — |
| Fixed assets | — | — | 329.05 | 323.15 | — | — |
| Trade receivables | — | — | 23.44 | 22.66 | — | — |
| Trade payables | — | — | 29.99 | 34.42 | — | — |
| Cash from operations | — | — | 87.18 | 52.61 | — | — |
| Cash from investing | — | — | −90.27 | −218.32 | — | — |
| Cash from financing | — | — | 25.29 | 192.59 | — | — |
| Net cash generated | — | — | 22.21 | 26.88 | — | — |
Key ratios and valuation
| Measure | Value | Basis |
|---|---|---|
| Indicative price | ₹155 | dealer reference, 17 Oct 2026 |
| Market cap | ₹2,924.21 Cr | price × 18,86,58,478 shares |
| P/E | 122.05x | price ÷ EPS ₹1.27 (FY26) |
| P/B | 9.2x | price ÷ book value ₹16.84 |
| EPS | ₹1.27 | per share, FY26 |
| Book value | ₹16.84 | per share, latest books |
| RoE | 5.87% | return on equity, latest FY |
| Debt / equity | 1.34 | latest balance sheet |
| Dividend yield | — | |
| Face value | ₹10 | per share |
| 52-week range | ₹142 – ₹160 | 284 dated quotes, last 12 months |
| Shares outstanding | 18,86,58,478 | per company record |
Shareholding pattern
| Category | Holder | % of equity |
|---|---|---|
| Promoters | Promoters | 65.4% |
| Institutions | Institutional (fii/dii) | 18.2% |
| Public | Public | 16.4% |
Promoters 65.4% · Institutions 18.2% · Public 16.4%
Management and promoters
| Name | Designation | Experience |
|---|---|---|
| Dr. K. Madeswaran | Chairman Cum Managing Director | — |
| Sri. T. Balachander | Director - Finance (cfo) | — |
| Dr. K. Chockalingam | Director | — |
| Cs. K. Rangasamy | Company Secretary | — |
| Sri. K. P. Alagesan | Director | — |
| Dr. Minu Madeswaran | Director | — |
| Dr. S. P. Thiruppathy | Independent Director | — |
| Sri. K. Muthusamy | Independent Director | — |
Business model
Royalcare Super Speciality Hospital Limited operates a multi-super-speciality hospital in Coimbatore. The company was incorporated in 2012 and its annual report says it commenced hospital operations in 2016 with this flagship facility. Its revenue comes from patient care and related healthcare activity, specifically in-patient services, out-patient services, pharmacy sales and dietary sales. The hospital also receives revenue for services rendered to patients who have not yet been discharged, recorded as unbilled revenue under its accounting policy.
The business purchases consumables, hospital stores and medical equipment, and uses related-party equipment leases where applicable. The annual report describes NABH, JCI, SRC and CARF accreditations for its multi-speciality hospital and records continued investment in medical equipment. The operating model is therefore an integrated hospital-provider model: clinical services are delivered through the hospital, with pharmacy and dietary products supporting patient care, and revenue recognised from healthcare services and supporting sales.
Corporate actions and events
| Date | Type | Detail | Ratio / amount | Source |
|---|---|---|---|---|
| Undated | Agm | 13th Annual General Meeting scheduled (27 Sep 2025) | — | Desk note |
Reports and filings
No filings uploaded yet.
Annual reports
- Royalcare Super Speciality Hospitals annual report 2024-25 (PDF)
- Royalcare Super Speciality Hospitals annual report 2023-24 (PDF)
- Royalcare Super Speciality Hospitals annual report 2022-23 (PDF)
- Royalcare Super Speciality Hospitals annual report 2021-22 (PDF)
Frequently asked questions
Where is Royal Care Hospital?
Royalcare Super Speciality Hospital runs a multi-speciality tertiary care hospital at Neelambur, Coimbatore, Tamil Nadu. The company was incorporated in 2012 and began clinical operations in 2015.
What is the ISIN of Royal Care Hospital shares?
INE02C801010, with a face value of ₹10 per share. The shares settle demat to demat through NSDL and CDSL.
How has the Royal Care Hospital unlisted share price moved?
On the desk’s dated price series, the indicative price is down 3.1% over three months, as of 17 Oct 2026. These are dated dealer references, not exchange prices.
What does Royalcare Super Speciality Hospital Limited do?
Royalcare Super Speciality Hospital Limited operates a large multi-speciality tertiary care hospital in Coimbatore, Tamil Nadu. It offers treatment across specialities such as cardiology, neurology, orthopaedics, oncology, nephrology, urology, gastroenterology and pulmonology, along with critical care, emergency and diagnostic services, serving the western Tamil Nadu region.
Is Royalcare Super Speciality Hospital listed, and how are its unlisted shares transferred?
No. Royalcare Super Speciality Hospital is currently an unlisted public company and is not traded on the NSE or BSE, and it has not filed a draft prospectus for an IPO. Its shares are held in dematerialised form and change hands through off-market unlisted-share transactions between a willing buyer and seller, settled by transferring shares between demat accounts. This is descriptive information only and not a recommendation to transact.
What determines the indicative price of Royalcare unlisted shares?
As an unlisted company, Royalcare has no exchange-quoted price. Its indicative price reflects what buyers and sellers negotiate in the over-the-counter market and is influenced by factors such as the company's reported financials, hospital occupancy and growth, broader sentiment toward the healthcare sector, demand and supply for the stock, and any IPO-related expectations. Indicative prices can vary across sources and over time.
What are the key fundamentals of Royalcare Super Speciality Hospital?
Royalcare Super Speciality Hospital Limited was incorporated in 2012 with its registered office in Coimbatore, Tamil Nadu. Its CIN is U85100TZ2012PLC018984 and ISIN is INE02C801010, with equity shares carrying a face value of ₹10 each. The company reported revenue of around ₹338 crore for FY2024 and operates with a paid-up equity base of approximately ₹205 crore.
Can I buy Royalcare Super Speciality Hospitals unlisted shares?
Royalcare Super Speciality Hospitals is not listed on a stock exchange, so its shares change hands off market, between existing holders and buyers. To buy through BuyUnlistedShares, send an enquiry with the quantity you have in mind. You need a demat account (NSDL or CDSL) and your PAN; the minimum ticket is ₹25,000, the same for every company on this site.
How is the Royalcare Super Speciality Hospitals unlisted share price set?
Unlisted shares have no exchange order book, so the price is set by demand and supply between buyers and sellers in the off-market (over-the-counter) market, and it moves with company news such as funding rounds, results and IPO filings. The ₹155 on this page is an indicative reference dated 17 Oct 2026. The price for an actual deal is confirmed in writing before you pay.
How are Royalcare Super Speciality Hospitals shares delivered?
Demat to demat. The shares are credited to your own demat account through NSDL or CDSL, and you pay only into the Gayatri Financial Synergy LLP company bank account, never to an individual.
Can I sell my Royalcare Super Speciality Hospitals unlisted shares?
Send a sell enquiry with the company and the quantity you hold. A person on the desk comes back to you, and if a deal is agreed, the shares move demat to demat from your account.
What is the Royalcare Super Speciality Hospitals unlisted share price today?
The indicative over-the-counter reference price is ₹155 per share as of 17 Oct 2026. It is a dated dealer reference, refreshed every working day.
Is Royalcare Super Speciality Hospitals listed on a stock exchange?
Not yet. Royalcare Super Speciality Hospitals changes hands in the unlisted market, over the counter and settle into your demat account through NSDL and CDSL.
What is the minimum investment in Royalcare Super Speciality Hospitals?
The minimum ticket is ₹25,000, the same for every company on the site.
How do I buy Royalcare Super Speciality Hospitals unlisted shares?
Send an enquiry with the quantity you have in mind. The desk replies with a dated quote, the paperwork list and the demat steps, and the shares settle demat to demat into your own account.
Is there a lock-in if Royalcare Super Speciality Hospitals lists?
Pre-IPO shareholders other than promoters are generally locked in for six months from the date of IPO allotment under SEBI ICDR regulation 17. The final offer document sets the exact terms.
Sources
- Royalcare Super Speciality Hospitals annual report 2024-25 · FY 2024-25 · royalcarehospital.in
- Royalcare Super Speciality Hospitals annual report 2023-24 · FY 2023-24 · royalcarehospital.in
- Royalcare Super Speciality Hospitals annual report 2022-23 · FY 2022-23 · royalcarehospital.in
- Royalcare Super Speciality Hospitals annual report 2021-22 · FY 2021-22 · royalcarehospital.in
- BuyUnlistedShares indicative price series for Royalcare Super Speciality Hospitals, dated daily · since 27 Nov 2025 (284 dated quotes) · buyunlistedshares.com
How to cite this page: BuyUnlistedShares, “Royalcare Super Speciality Hospitals unlisted share price”, https://buyunlistedshares.com/unlisted-shares/royalcare-super-speciality-hospitals, as of 17 Oct 2026.
Other Consumer unlisted shares
- A V Thomas & Co. Limited · ₹12,500
- Anglo French Drugs and Industries · ₹1,075
- Anheuser Busch Inbev India (AB InBev) · ₹555
- Apollo Fashion International · ₹44
- Arch Pharmalabs Limited · ₹85
- Auckland Jute Co. Limited · ₹189
Enquire to buy Royalcare Super Speciality Hospitals · Sell a holding
Indicative reference price, dated. BuyUnlistedShares is India's premium unlisted shares desk, run by Gayatri Financial Synergy LLP. In the market since 2002. Data as of 17 Oct 2026.
Before you buy: guides
- How to evaluate an unlisted company before investing
- How Unlisted Share Prices Are Discovered When There Is No Live Order Book
- The risks of buying unlisted and pre-IPO shares in India
- Unlisted Shares Lock-In Period: What Every Investor Must Know (2026)
- Can an NRI invest in unlisted shares in India?
All unlisted shares · IPO calendar · Research & learning · Send an enquiry · Calculators · Jobs · About · Contact · Privacy · Terms · Disclaimer · Grievance redressal
Guides: Start investing · Evaluate a company · How prices are set · Risks · Lock-in periods · After the IPO · Sell ESOPs · NRI investors · Buybacks · Choosing a platform
BuyUnlistedShares (BUS) · Gayatri Financial Synergy LLP (LLPIN ACU-4678) · SCO-39, 1st Floor, HUDA Market, Sector-7, Faridabad, Haryana 121006 · +91 916-916-59-59
